Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
Rhea-AI Summary
Baird Medical (NASDAQ: BDMD) sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum in Guangzhou, China. The company showcased its advanced microwave ablation (MWA) technology for thyroid treatments, which features larger ablation zones and shorter treatment times. The event, hosted by Guangdong Provincial People's Hospital, brought together leading medical experts to discuss standardized treatment protocols for thyroid diseases. Chairwoman Haimei Wu emphasized the company's commitment to advancing solutions for thyroid disease management and improving patient outcomes globally.
Positive
- Company's MWA technology offers improved features including larger ablation zones and shorter treatment times
- Strategic presence and networking opportunities at a major medical forum in China
- Strengthening market position in thyroid disease treatment sector
Negative
- None.
News Market Reaction
On the day this news was published, BDMD declined 12.28%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
This prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in
As a sponsor, Baird Medical presented its advanced microwave ablation technology, designed to provide precise, efficient, and minimally invasive options for thyroid treatments. Attendees had the opportunity to learn about Baird's innovations, which enable larger ablation zones and shorter treatment times, setting a new standard for minimally invasive procedures.
"Baird Medical is thrilled to sponsor and contribute to this highly respected forum, which underscores our dedication to advancing cutting-edge solutions for thyroid disease management," said Haimei Wu, Chairwoman of Baird Medical. "Through our participation, we aim to support medical professionals with the tools and expertise needed to improve patient outcomes globally."
The forum also enabled Baird Medical to engage in meaningful discussions with leading experts, enhance collaborations, and highlight its commitment to expanding the reach of innovative treatments both within
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-microwave-ablation-mwa-technology-at-the-7th-thyroid-disease-forum-in-china-302315066.html
SOURCE BDMD
FAQ
What technology did Baird Medical (BDMD) showcase at the 2024 Thyroid Disease Forum in China?
Where was the 7th Thyroid Disease Forum that Baird Medical (BDMD) sponsored in 2024?
What are the key features of Baird Medical's (BDMD) microwave ablation technology?
